Diversified Trust Co Takes Position in Masimo Corporation $MASI

Diversified Trust Co bought a new stake in shares of Masimo Corporation (NASDAQ:MASI) during the 1st quarter, HoldingsChannel.com reports. The fund bought 4,685 shares of the medical equipment provider’s stock, valued at approximately $833,000.

Several other institutional investors have also bought and sold shares of MASI. Corient Private Wealth LLC raised its position in Masimo by 1.2% in the 4th quarter. Corient Private Wealth LLC now owns 340,230 shares of the medical equipment provider’s stock valued at $44,250,000 after buying an additional 4,015 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Masimo during the 4th quarter valued at $116,000. Pacer Advisors Inc. boosted its holdings in Masimo by 21.1% during the 4th quarter. Pacer Advisors Inc. now owns 7,360 shares of the medical equipment provider’s stock worth $957,000 after acquiring an additional 1,280 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of Masimo in the 4th quarter worth $258,000. Finally, T. Rowe Price Investment Management Inc. grew its stake in shares of Masimo by 9.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock worth $303,061,000 after acquiring an additional 203,395 shares in the last quarter. Institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

MASI stock opened at $179.95 on Thursday. The stock’s fifty day simple moving average is $178.93 and its two-hundred day simple moving average is $162.74. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. Masimo Corporation has a 1-year low of $125.94 and a 1-year high of $179.99. The stock has a market cap of $9.42 billion, a P/E ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Finally, Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Nine investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Masimo presently has an average rating of “Hold” and an average price target of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.